Fetal cardiac interventions

  • N. Yashchuk National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • O. Koval National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • I. Ditkivskyy National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • B. Cherpak National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • I. Lukianova Institute of Pediatrics, Obstetrics and Gynecology National Academy of Medical Sciences of Ukraine (Kyiv)
  • Ju. Davydova Institute of Pediatrics, Obstetrics and Gynecology National Academy of Medical Sciences of Ukraine (Kyiv)
  • V. Lazoryshynetz National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
Keywords: congenital heart defects, fetal cardiac interventions, fetal heart, balloon valvuloplasty

Abstract

Congenital heart defects are most frequent in the structure of all malformations with prevalence of 6–9 per 1,000 life newborns. CHD often are the reason of fetal and newborns deaths. Modern fetoechocardiography allows a more accurate and timely diagnosis of CHD, to clarify the pathophysiological mechanisms of their occurrence and the natural genesis. Described «mechanical» and «hemodynamic» theories of some CHD pathogenesis, the essence of which is the ability to prevent the progression of the malformations development in eliminating the etiological factor. Thus, timely effective balloon valvuloplasty stenosis of the aortic and pulmonary valves in the fetus in early pregnancy can prevent the development of hypoplastic left and right heart syndroms. The results of international research had showed that intervention in the fetus allows switch the circulation from single heart to a normal biventricular. Fetal intervention is a perspective trend in the national cardiac surgery and will improve the function of the fetus heart, the length and quality of babies life, reduce prenatal mortality.

References

1. Francine R. Congenital Anomalies: Prevalence and Risk Factors [Text] / R. Francine, S. Pascale, H. Aline // Universal Journal of Public Health. – 2014. – Vol. 2 (2). – P. 58–63.

2. Linde D. Birth prevalence of congenital heart disease worldwide. A systematic review and meta–analysis [Text] / D. Linde, E. Konings [et al.] // J Am Coll Cardiol. – 2011. – Vol. 58. – Р. 2241–2247.

3. Dolk H. Congenital Heart Defects in Europe Prevalence and Perinatal Mortality, 2000 to 2005 [Text] / H. Dolk, M. Loane, E. Garne // Circulation – 2011. – Volume 123. – P. 841-849.

4. Hamilton L. E. Grown–Up Congenital Heart Disease and Sudden Death in a Medical Examiner’s Population [Text] / L. E. Hamilton, E. О. Lew; E. W. Matshes // Journal of Forensic Sciences. – 2011. – Vol. 56. – N 5. – P. 1206–1212.

5. Зіньковський М. Ф. Принципи лікування дітей з вродженими вадами серця [Текст] / М. Ф. Зіньковський, В. В. Лазоришинець, Руденко Н. Н. // Доктор. – 2003. – № 2. – С. 23–25.

6. Donofrio М. Т. Diagnosis and Treatment of Fetal Cardiac Disease A Scientific Statement From the American Heart Association [Text] / M. T. Donofrio, A. J. Moon-Grady, L. K. Hornberger [et al.] // Circulation. – May 13, 2014. – P. 1–61.

7. Tworetzky W. Hypoplastic Left Heart Syndrome: Candidate Selection, Technique, and Balloon Dilation of Severe Aortic Stenosis in the Fetus: Potential for Prevention and result of successful intervention [Text] / W. Tworetzky, L. Wilkins-Haug, R. W. Jennings [et al.] // Circulation –2004. – 110. – Р. 2125–2131.

8. Tworetzky W. In Utero Valvuloplasty for Pulmonary Atresia With Hypoplastic Right Ventricle: Techniques and outcomes [Text] / W. Tworetzky, D. B. McElhinney // Pediatrics. – 2009. – Vol. 124. – Р. 510–518.

9. Kohl T. World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction [Text] / Kohl T., Sharland G., Allan L. D. [et al.] // Am. J. Cardiol. – 2000. – Vol. 85. –Р. 1230–3.

10. Moon-Grady A. J. International Fetal Cardiac Intervention Registry: A Worldwide Collaborative Description and Preliminary Outcomes [Text] / Moon-Grady A. J., Morris S. A., Belfort M. [et al.] // J. Am. Coll. Cardiol. –2015. – Jul 28. – Vol. 66 (4). – Р. 388–99.

11. Freud L. R. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients [Text] / Freud L. R., McElhinney D. B., Marshall A. C., Marx G. R. [et al.] // Circulation. – 2014. – Aug 19. – Vol. 130 (8). – Р. 638–45.

12. Feinstein J. A. Hypoplastic Left Heart Syndrome Current Considerations and Expectations [Text] / Feinstein J. A., D. Woodrow Benson, A. M. Dubin [et al.] // JACC. – 2012. – Vol. 59. – N 1. – Suppl. S. – Р. 1–42.

13. Tulzer G. Fetal cardiac interventions: Rationale, risk and benefit [Text] / Tulzer G., Arzt W. // Semin Fetal Neonatal Med. – 2013. – Vol. 18 (5). – Р. 298–301.
Published
2016-05-16
How to Cite
Yashchuk, N., Koval, O., Ditkivskyy, I., Cherpak, B., Lukianova, I., Davydova, J., & Lazoryshynetz, V. (2016). Fetal cardiac interventions. Ukrainian Journal of Cardiovascular Surgery, (1 (24), 91-94. Retrieved from http://cvs.org.ua/index.php/ujcvs/article/view/278
Section
CONGENITAL HEART DEFECTS